Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program

(2016) Richard B Lipton et al.   CEPHALALGIA

Results of the Treatment of Chronic, Refractory CRPS with Ketamine Infusions: a Preliminary Report

(2016) P. Puchalski et al.   Handchirurgie Mikrochirurgie Plastische Chirurgie

Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey

(2016) Andrew Messali et al.   HEADACHE

Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use

(2016) Charles P. Taylor et al.   PHARMACOLOGY & THERAPEUTICS

The use of ketamine as an antidepressant: a systematic review and meta-analysis

(2015) Caoimhe M. Coyle et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Involvement of NMDA receptor subtypes in cortical spreading depression in rats assessed by fMRI

(2015) Artem Shatillo et al.   NEUROPHARMACOLOGY

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

(2014) Aubrey Manack Adams et al.   CEPHALALGIA

The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex

(2014) Renán Sánchez-Porras et al.   NEUROPHARMACOLOGY

Ketamine for chronic pain: risks and benefits

(2013) Marieke Niesters et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Glutamate and migraine: From Ikeda to the 21st century

(2013) Nabih M Ramadan   CEPHALALGIA

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Disability and quality of life in headache: where we are now and where we are heading

(2013) D. D’Amico et al.   NEUROLOGICAL SCIENCES

A randomized controlled trial of intranasal ketamine in migraine with prolonged aura

(2013) S. K. Afridi et al.   NEUROLOGY

Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan

(2012) Shuu-Jiun Wang et al.   CEPHALALGIA

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

(2012) Dawn C. Buse et al.   HEADACHE

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine

(2011) R. B. Lipton et al.   NEUROLOGY

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

(2010) AM Blumenfeld et al.   CEPHALALGIA

Defining the Pharmacologically Intractable Headache for Clinical Trials and Clinical Practice

(2010) Stephen D. Silberstein et al.   HEADACHE

Ultra-Low Dose Ketamine and Memantine Treatment for Pain in an Opioid-Tolerant Oncology Patient

(2008) Lucinda A. Grande et al.   ANESTHESIA AND ANALGESIA

Rational Combination Therapy in Refractory Migraine

(2008) B. Lee Peterlin et al.   HEADACHE

Mexiletine for Refractory Chronic Daily Headache: A Report of Nine Cases

(2008) Michael J. Marmura et al.   HEADACHE

Memantine in the Preventive Treatment of Refractory Migraine

(2008) Marcelo Bigal et al.   HEADACHE

Defining Refractory Migraine and Refractory Chronic Migraine: Proposed Criteria From the Refractory Headache Special Interest Section of the American Headache Society

(2008) Elliott A. Schulman et al.   HEADACHE